Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles

Maria S. Novak, Gabriel E. Büchel, Bernhard K. Keppler, Michael A. Jakupec

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Since the discovery that nitric oxide (NO) is a physiologically relevant molecule, there has been great interest in the use of metal nitrosyl compounds as antitumor pharmaceuticals. Particularly interesting are those complexes which can deliver NO to biological targets. Ruthenium- and osmium-based compounds offer lower toxicity compared to other metals and show different mechanisms of action as well as different spectra of activity compared to platinum-based drugs. Novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles were studied to elucidate their cytotoxicity and possible interactions with DNA. Apoptosis induction, changes of mitochondrial transmembrane potential and possible formation of reactive oxygen species were investigated as indicators of NO-mediated damage by flow cytometry. Results suggest that ruthenium- and osmium-nitrosyl complexes with the general formula (indazolium)[cis/trans-MCl4(NO)(1H-indazole)] have pronounced cytotoxic potency in cancer cell lines. Especially the more potent ruthenium complexes strongly induce apoptosis associated with depolarization of mitochondrial membranes, and elevated reactive oxygen species levels. Furthermore, a slight yet not unequivocal trend to accumulation of intracellular cyclic guanosine monophosphate attributable to NO-mediated effects was observed.
Original languageEnglish (US)
Pages (from-to)347-356
Number of pages10
JournalJBIC Journal of Biological Inorganic Chemistry
Volume21
Issue number3
DOIs
StatePublished - Mar 9 2016

Fingerprint

Dive into the research topics of 'Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles'. Together they form a unique fingerprint.

Cite this